Treatment Effects Upon Prolactin and Soluble Receptor of Interleukin-2 in Psoriatic Patients

MAEDICA – a Journal of Clinical Medicine
doi 10.26574/maedica.2018.13.1.25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

TARUS Media

Related search

Soluble Interleukin 2 Receptor in Patients With Chronic Hepatitis Type B.

Acta Hepatologica Japonica
Hepatology
1988English

Soluble Interleukin 2 Receptor and Interleukin 1α in Toxic Epidermal Necrolysis

Archives of Dermatology
2002English

Studies on the Soluble Interleukin-2 Receptor in Patients With Bronchial Asthma

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1994English

The Serum Concentration of Soluble Interleukin-2 Receptor in Patients With Kawasaki Disease

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2017English

Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Levels in Depressed Patients in Estonia

Medicina
Medicine
2009English

Serum Concentration of Osteopontin and Interleukin 17 in Psoriatic Patients

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Detection of Soluble Interleukin-2 Receptor and Soluble Intercellular Adhesion Molecule-1 in the Effusion of Otitis Media With Effusion

Mediators of Inflammation
ImmunologyCell Biology
1995English

Monitoring Soluble Interleukin-2 Receptor Levels in Related and Unrelated Donor Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
1998English

Psychological Effects of Dopamine Agonist Treatment in Patients With Hyperprolactinemia and Prolactin Secreting Adenomas

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy